Quarterly report pursuant to Section 13 or 15(d)

LIQUIDITY AND GOING CONCERN CONSIDERATIONS (Details Narrative)

v3.10.0.1
LIQUIDITY AND GOING CONCERN CONSIDERATIONS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Nov. 09, 2017
Oct. 05, 2017
Aug. 02, 2017
Jul. 20, 2017
Jul. 17, 2017
Dec. 23, 2016
Nov. 17, 2016
Oct. 07, 2016
Sep. 02, 2016
Apr. 06, 2016
Dec. 30, 2015
Sep. 30, 2018
Sep. 30, 2018
Sep. 30, 2017
Mar. 31, 2018
Feb. 12, 2018
Feb. 08, 2018
Dec. 30, 2016
Current liabilities                       $ 4,359,995 $ 4,359,995   $ 40,251,961      
Current assets                       5,502,791 5,502,791   1,664,775      
Working capital deficit                       $ 1,100,000 1,100,000   $ 38,600,000      
Change in working capital deficit                         $ 39,700,000          
Proceeds from note payable                           $ 150,000        
Repayment of note payable                           $ 1,360,087        
Warrant exercise price                       $ 321.01 $ 321.01   $ 12.94      
Number of shares issued           1,067,600                        
Proceeds from purchase of shares                         $ 9,000,000          
Principal balance of short-term promissory note                       $ 495,000 495,000   $ 37,438,617      
Debt discount                       $ 384,305 $ 384,305          
Series C Preferred Stock [Member]                                    
Stock conversion price (in dollars per share)                             $ 3.25      
Series B Preferred Stock [Member]                                    
Number of shares issued                         1,751          
Institutional Investors [Member]                                    
Shares called by warrant                               58,052,599    
Institutional Investors [Member] | First Warrant [Member]                                    
Shares called by warrant                                 110,447,753  
Number of shares issued               32,400                    
Number of common stock issued upon warrant exercise               55,385                    
Number of additional common stock issued upon warrant exercise               101,710                    
Description of beneficial ownership limitation               <p style="font: 12pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><font style="font: 10pt Times New Roman, Times, Serif">Beneficial ownership limitation (4.99% of the Company’s outstanding common stock).</font></p>                    
Proceeds from warrant exercises               $ 4,500,000                    
Placement agent fees               $ 427,500                    
Institutional Investors [Member] | First Warrant [Member] | Redeemable Convertible Subordinated Debenture [Member]                                    
Shares called by warrant                   55,385                
Warrant exercise price                   $ 3.25                
Funding Agreement [Member] | Vantage Fund [Member]                                    
Proceeds from note payable       $ 30,000 $ 120,000                          
Repayment of note payable $ 150,000                                  
Funding Agreement [Member] | Vantage Fund [Member] | Warrants [Member]                                    
Warrant term     3 years                              
Shares called by warrant     1,600,000                              
Warrant exercise price     $ 0.25                              
Securities Purchase Agreement [Member] | Series C Preferred Stock [Member]                                    
Number of shares issued                       735 945          
Securities Purchase Agreement [Member] | Institutional Investors [Member]                                    
Share purchase agreement value   $ 16,000,000                                
Securities Purchase Agreement [Member] | Institutional Investors [Member] | 6% Series C Redeemable Convertible Preferred Stock [Member]                                    
Shares of common stock issued on conversion                   64,738                
Stock conversion price (in dollars per share)                   $ 3.25                
Original issue discount                   5.00%                
Number of shares issued             474   53 527                
Proceeds from sale of shares             $ 4,500,000   $ 500,000                  
Securities Purchase Agreement [Member] | Institutional Investors [Member] | Series C Preferred Stock [Member]                                    
Shares of common stock issued on conversion                       440,002 1,212,326 (123)        
Number of shares issued   1,684                         633      
Proceeds from purchase of shares   $ 16,000,000                                
Securities Purchase Agreement [Member] | Institutional Investors [Member] | Series C Preferred Stock [Member] | Seventh Closing [Member]                                    
Number of shares issued   525                                
Proceeds from purchase of shares   $ 5,000,000                                
Securities Purchase Agreement [Member] | Institutional Investors [Member] | Redeemable Convertible Subordinated Debenture [Member]                                    
Notes payable                   $ 530,000                
Interest rate                   6.00%                
Proceeds from issuance of debt                   $ 500,000                
Shares of common stock issued on conversion                   163,077                
Stock conversion price (in dollars per share)                   $ 3.25                
Original issue discount                   5.00%                
Debt discount                   $ 30,000                
Securities Purchase Agreement [Member] | Institutional Investors [Member] | First Warrant [Member] | Redeemable Convertible Subordinated Debenture [Member]                                    
Number of common stock issued upon warrant exercise                   55,385                
Securities Purchase Agreement [Member] | Institutional Investors [Member] | Second Warrant [Member] | 6% Series C Redeemable Convertible Preferred Stock [Member]                                    
Shares called by warrant                   44,444                
Warrant exercise price                   $ 112.50                
Asset Purchase Agreement [Member] | 23 Different Entities & Individuals [Member] | Mid-Continent Region [Member]                                    
Cash paid for acquisition                     $ 4,975,000              
Asset Purchase Agreement [Member] | 23 Different Entities & Individuals [Member] | Mid-Continent Region [Member] | Common Stock [Member]                                    
Number of shares issued in acquisition                     520,387              
Asset Purchase Agreement [Member] | Series B Preferred Stock [Member] | 23 Different Entities & Individuals [Member] | Mid-Continent Region [Member]                                    
Number of shares issued in acquisition                     552,000              
Asset Purchase Agreement [Member] | Seller 2 [Member]                                    
Agreed assets value                                   $ 80,697,710
Deficiency for agreed assets value                                   1,030,941
Value of assets acquired in clearing of deficiency                                   $ 1,000,000
Purchase Agreement [Member] | 23 Different Entities & Individuals [Member] | Mid-Continent Region [Member]                                    
Repayment of debt                     $ 30,600,000